Literature DB >> 2091332

Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa.

L K Basco1, J Le Bras.   

Abstract

Twenty freshly isolated strains of Plasmodium falciparum from non-immune and semi-immune patients infected in Central and West Africa were tested for in vitro drug sensitivity to chloroquine alone and to a combination of chloroquine and desipramine without prior adaptation to continuous culture. Combination of desipramine at 625 nmol/litre and chloroquine reversed resistance totally (IC50 less than 100 nmol/litre) in all 14 chloroquine-resistant isolates. No effect on chloroquine sensitivity was noted in the 6 chloroquine-sensitive isolates. These observations provide additional evidence that reversal of chloroquine resistance in the presence of desipramine is not a phenomenon unique to culture-adapted strains and that desipramine may exert the same potentiating effect in vivo, provided that effective plasma concentration can be attained without serious side-effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091332     DOI: 10.1016/0035-9203(90)90006-z

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Structural analysis of chloroquine resistance reversal by imipramine analogs.

Authors:  A K Bhattacharjee; D E Kyle; J L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum.

Authors:  L K Basco; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

4.  Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates.

Authors:  J Bickii; L K Basco; P Ringwald
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.

Authors:  A M Ndifor; R E Howells; P G Bray; J L Ngu; S A Ward
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.

Authors:  A F Coutaux; J J Mooney; D F Wirth
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

7.  Dihydroethanoanthracene derivatives as in vitro malarial chloroquine resistance reversal agents.

Authors:  Julie Millet; Marylin Torrentino-Madamet; Sandrine Alibert; Christophe Rogier; Christiane Santelli-Rouvier; Joel Mosnier; Eric Baret; Jacques Barbe; Daniel Parzy; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

8.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

9.  In vitro increase in chloroquine accumulation induced by dihydroethano- and ethenoanthracene derivatives in Plasmodium falciparum-parasitized erythrocytes.

Authors:  Bruno Pradines; Sandrine Alibert; Carole Houdoin; Christiane Santelli-Rouvier; Joel Mosnier; Thierry Fusai; Christophe Rogier; Jacques Barbe; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

10.  Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.

Authors:  Jane X Kelly; Martin J Smilkstein; Roland A Cooper; Kristin D Lane; Robert A Johnson; Aaron Janowsky; Rozalia A Dodean; David J Hinrichs; Rolf Winter; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.